Swara Baby Products, a key supplier for FirstCry, has announced plans for a ₹1,000 crore IPO. The issue consists of a ₹500 crore fresh capital raise and a ₹500 crore offer for sale. Investors should note the company’s strong reliance on FirstCry, which acts as both its promoter and largest customer.
What Happened
Swara Baby Products has filed for an Initial Public Offering (IPO) aiming to raise ₹1,000 crore. The offering is split equally between a fresh issue of shares worth ₹500 crore and an offer for sale (OFS) of another ₹500 crore by existing shareholders. The company plans to use the new funds to set up a manufacturing plant in Madhya Pradesh, pay off existing debt, and support potential acquisitions to expand its footprint in the hygiene products sector.
The FirstCry Connection
The relationship between Swara Baby Products and Brainbees Solutions, the parent company of FirstCry, is central to this story. Brainbees has evolved from being an investor to becoming the majority promoter with a 76.59% stake as of December 2025. This ownership structure is unique because Brainbees is also Swara’s largest customer, accounting for over 22% of its total revenue in the fiscal year 2026. Swara manufactures private-label goods, such as BabyHug diapers, exclusively for the FirstCry platform.
Financial Performance Snapshot
For the fiscal year 2026, the company reported revenue of ₹1,212.44 crore, representing a 26% growth compared to the previous year. Profit after tax reached ₹95.59 crore, an 18% increase, while EBITDA, a measure of operating profitability, stood at ₹192.77 crore. The company operates four manufacturing facilities in Madhya Pradesh using automated production lines to meet demand for diapers and sanitary napkins.
Business Context and Strategy
The Indian hygiene products market is a growing sector, with projections suggesting it could expand significantly by 2030. Swara has been active in expanding its portfolio, having acquired companies like KAEHPL and Solis Hygiene in late 2025. This strategy aims to diversify its product range beyond basic baby care into the broader hygiene category.
How Investors May Read This
For potential investors, the primary monitorable is customer concentration risk. While the partnership with FirstCry provides stable and predictable order volumes, it also means Swara’s financial health is closely tied to the performance and strategy of the FirstCry platform. If the nature of this commercial arrangement changes or if FirstCry faces a demand slowdown, Swara’s revenue could be directly affected. Additionally, investors will need to watch how efficiently the company manages its debt after the IPO, as repaying loans is a stated objective of the fresh issue. The timeline for setting up the new manufacturing facility and its impact on future margins will also be key metrics for tracking growth.